College of Medicine

Medicine & Life Sciences

1. Neoplasms 100%
2. Therapeutics 85%
3. Child 55%
4. Pancreatic Neoplasms 52%
5. Proteins 52%
6. Pediatrics 48%
7. HIV-1 46%
8. HIV 45%
9. Liver 45%
10. Rheumatoid Arthritis 45%
11. Survival 42%
12. Genes 42%
13. Transplants 41%
14. Chronic Obstructive Pulmonary Disease 39%
15. Infections 37%
16. Brain 36%
17. Lung 36%
18. Guidelines 35%
19. Kidney 34%
20. Ethanol 34%
21. Heart Failure 34%
22. Growth 33%
23. Non-Hodgkin's Lymphoma 33%
24. Wounds and Injuries 32%
25. Lymphoma 31%
26. Epithelial Cells 31%
27. Mortality 31%
28. Macrophages 31%
29. Drug Therapy 30%
30. Breast Neoplasms 29%
31. Neoplasm Metastasis 28%
32. Pharmaceutical Preparations 28%
33. Mutation 28%
34. DNA 27%
35. Inflammation 27%
36. In Vitro Techniques 27%
37. Liver Transplantation 27%
38. Safety 26%
39. Adenocarcinoma 26%
40. Population 26%
41. Alcohols 26%
42. Transplantation 25%
43. Stem Cells 25%
44. T-Lymphocytes 25%
45. Mucins 25%
46. Peptides 24%
47. Lymphoma, Large B-Cell, Diffuse 23%
48. Biomarkers 22%
49. Prostatic Neoplasms 22%
50. Apoptosis 22%
51. Phenotype 21%
52. Eye 21%
53. Education 21%
54. Health 20%
55. Coronavirus 20%
56. Cytokines 20%
57. Incidence 20%
58. Practice Guidelines 20%
59. Fibroblasts 20%
60. Carcinogenesis 20%
61. Physicians 20%
62. Animals 19%
63. Databases 19%
64. Bone Marrow 19%
65. Serum 19%
66. Antibodies 19%
67. Cell Line 19%
68. Clinical Trials 19%
69. Transplant Recipients 19%
70. Recurrence 19%
71. Confidence Intervals 19%
72. Radiotherapy 18%
73. Virus Diseases 18%
74. MicroRNAs 18%
75. Acetaldehyde 18%
76. Gene Expression 18%
77. Cell Proliferation 17%
78. Systematic Reviews 17%
79. Placebos 17%
80. Hodgkin Disease 17%
81. Staphylococcus aureus 17%
82. Microbubbles 17%
83. Bone and Bones 17%
84. Surgeons 16%
85. Enzymes 16%
86. Exercise 16%
87. Urinary Bladder 16%
88. Heart 16%
89. Equipment and Supplies 16%
90. Pandemics 16%
91. Neurons 16%
92. Biofilms 16%
93. Technology 16%
94. Phosphorylation 16%
95. Transforming Growth Factors 16%
96. Skin 16%
97. Costs and Cost Analysis 16%
98. Viruses 16%
99. Randomized Controlled Trials 16%
100. Anti-Bacterial Agents 16%